Efficacy of Administration of ACE-Inhibition on Autonomic and Peripheral Neuropathy in Patients With Diabetes Mellitus
NCT03031834 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2017-01-26
Summary
Patients with diabetes mellitus and definite autonomic and peripheral neuropathy were randomized to receive quinapril or no treatment for 2 years.
Conditions
- Diabetic Autonomic Neuropathy
Interventions
- DRUG
-
Quinapril
Sponsors & Collaborators
-
Aristotle University Of Thessaloniki
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-01-31
- Primary Completion
- 2001-05-31
More Related Trials
-
A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain
NCT00375960 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Painful Diabetic Neuropathy
NCT00980746 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain
NCT00548925 ·Status: COMPLETED ·Phase: PHASE2
-
DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain
NCT02318706 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of NRD135S.E1 in Peripheral Neuropathic Pain in Diabetic Patients
NCT02345291 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Safety, Tolerability and Efficacy of V3381 in Patients With Diabetic Peripheral Neuropathic Pain
NCT00794430 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y
NCT01056315 ·Status: TERMINATED ·Phase: PHASE2
-
Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic Neuropathy
NCT00073034 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With PDN and Good Pain Reporting Ability
NCT01928381 ·Status: COMPLETED ·Phase: PHASE2
-
Study in Neuropathic Pain Patients With Peripheral Nerve Injury
NCT00969059 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy
NCT01201317 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic Pain
NCT01820715 ·Status: COMPLETED ·Phase: PHASE1
-
Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China
NCT00408993 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy
NCT02372578 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain
NCT04688671 ·Status: COMPLETED ·Phase: PHASE2
-
Eslicarbazepine Acetate as Therapy in Diabetic Neuropathic Pain
NCT01129960 ·Status: TERMINATED ·Phase: PHASE3
-
A Study for the Treatment of Painful Diabetic Neuropathy
NCT00058968 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain
NCT01345045 ·Status: COMPLETED ·Phase: PHASE2
-
The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain
NCT00376454 ·Status: COMPLETED ·Phase: PHASE2
-
Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy
NCT04678895 ·Status: RECRUITING ·Phase: PHASE2
-
An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain
NCT00385671 ·Status: COMPLETED ·Phase: PHASE4
-
Maintenance of Effect of Duloxetine in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
NCT00322621 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain
NCT00576277 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of RTA 901 (BIIB143) in Participants With Diabetic Peripheral Neuropathic Pain
NCT05895552 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of C-Peptide on Diabetic Peripheral Neuropathy
NCT00278980 ·Status: COMPLETED ·Phase: PHASE2